sulfinosine has been researched along with Cell Transformation, Neoplastic in 1 studies
*Cell Transformation, Neoplastic: Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dačević, M; Isaković, A; Isaković, AM; Milošević, Z; Pešić, M; Podolski-Renić, A; Rakić, L; Ruždijić, S; Stanković, T | 1 |
1 other study(ies) available for sulfinosine and Cell Transformation, Neoplastic
| Article | Year |
|---|---|
Purine nucleoside analog--sulfinosine modulates diverse mechanisms of cancer progression in multi-drug resistant cancer cell lines.
Topics: Apoptosis; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Autophagy; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Transformation, Neoplastic; Doxorubicin; Drug Resistance, Multiple; Gene Expression Regulation, Neoplastic; Glioblastoma; Glutamate-Cysteine Ligase; Glutathione; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Purine Nucleosides; Reactive Oxygen Species; Vascular Endothelial Growth Factor A | 2013 |